Your Health Plan:
Your Health Plan:
Not SelectedVIMIZIM (elosulfase alfa) is a biologic prescription drug for treatment of Mucopolysaccharidosis, MPS-IV-A. VIMIZIM is a hydrolytic lysosomal glycosaminoglycan-specific enzyme. It is available in the form of intravenous injection.
See full Prescribing Information for important safety information and clinical studies.
Cash price for 30-day supply is $1600-1900.
Patient Assistance Prorgams are found:
No other option is found for VIMIZIM
